These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1316094)

  • 1. Chronic granulomatous disease.
    Dinauer MC; Orkin SH
    Annu Rev Med; 1992; 43():117-24. PubMed ID: 1316094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of the autosomal recessive forms of chronic granulomatous disease.
    Curnutte JT
    Immunodefic Rev; 1992; 3(2):149-72. PubMed ID: 1554499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease.
    Dinauer MC
    Crit Rev Clin Lab Sci; 1993; 30(4):329-69. PubMed ID: 8110374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic granulomatous disease: diagnosis and classification at the molecular level.
    Hopkins PJ; Bemiller LS; Curnutte JT
    Clin Lab Med; 1992 Jun; 12(2):277-304. PubMed ID: 1611821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of chronic granulomatous disease.
    Dinauer MC; Orkin SH
    Immunodefic Rev; 1988; 1(1):55-69. PubMed ID: 3078710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for chronic granulomatous disease.
    Kume A; Dinauer MC
    J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
    Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT
    Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic granulomatous disease. Molecular genetics.
    Dinauer MC; Orkin SH
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):225-40. PubMed ID: 3292508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NADPH oxidase and chronic granulomatous disease.
    Segal AW
    Mol Med Today; 1996 Mar; 2(3):129-35. PubMed ID: 8796870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagocytic NADPH oxidase and its role in chronic granulomatous disease.
    Pallister CJ; Hancock JT
    Br J Biomed Sci; 1995 Jun; 52(2):149-56. PubMed ID: 8520251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic granulomatous disease: towards gene therapy.
    Thrasher A; Segal A; Casimir C
    Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The respiratory burst oxidase.
    Babior BM
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):201-12. PubMed ID: 2839456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma is effective in reducing infections in the mouse model of chronic granulomatous disease (CGD).
    Jackson SH; Miller GF; Segal BH; Mardiney M; Domachowske JB; Gallin JI; Holland SM
    J Interferon Cytokine Res; 2001 Aug; 21(8):567-73. PubMed ID: 11559434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic granulomatous disease: more than the lack of superoxide?
    Geiszt M; Kapus A; Ligeti E
    J Leukoc Biol; 2001 Feb; 69(2):191-6. PubMed ID: 11272268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies.
    Tauber AI; Borregaard N; Simons E; Wright J
    Medicine (Baltimore); 1983 Sep; 62(5):286-309. PubMed ID: 6353131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections.
    Khan TA; Kalsoom K; Iqbal A; Asif H; Rahman H; Farooq SO; Naveed H; Nasir U; Amin MU; Hussain M; Tipu HN; Florea A
    Microb Pathog; 2016 Nov; 100():163-169. PubMed ID: 27666509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects.
    Morel F; Doussiere J; Vignais PV
    Eur J Biochem; 1991 Nov; 201(3):523-46. PubMed ID: 1657601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and current management of chronic granulomatous disease.
    Forrest CB; Forehand JR; Axtell RA; Roberts RL; Johnston RB
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):253-66. PubMed ID: 2839458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.